Skip to content

Clinical and Genetic Factors Associated With Psychotic Symptoms Among Cocaine Abusers

Multicentric Descriptive Cross-sectional Study Evaluating Cocaine Users in Treatment Center

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01569347
Acronym
PSYCHOCOKE
Enrollment
417
Registered
2012-04-03
Start date
2012-04-30
Completion date
2016-11-30
Last updated
2016-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine-induced Psychotic Disorder During Intoxication

Keywords

Cocaine, Cocaine-induced psychosis, Genetic, Clinical, Biological

Brief summary

The aim of this study is to determine the clinical, genetic and environmental factors associated with the phenotype severe psychotic symptoms caused by cocaine.

Detailed description

The second purpose is to include gene x environment interaction and to analyse the factors associated with the presence or the absence of severe psychotic symptoms induced by cocaine.

Interventions

OTHERInterviews

Interviews

OTHERBlood sample

Blood sample

Hair sample

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults, cocaine users, who have signed an informed consent

Exclusion criteria

* Poor venous condition (for blood samples), specially protected people, non French speaking, people who refuse to sign the consent.

Design outcomes

Primary

MeasureTime frameDescription
causes and protective factors of Cocaine Induced Psychosis CIPup to one day after taking cocaine1. clinical data 2. biologic data 3. genetic data

Secondary

MeasureTime frameDescription
gene, environment interactions associated with CIPup to one day after taking cocaineclinical and genetic data

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026